Snippet Search

Searching 12,405,461 documents.
Discover how a particular term or phrase is used in scientific literature

Showing 1 to 25 of 434 matching articles

Results per page:

... from colorectal and appendiceal cancer.  Mitomycin 
Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis
Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis
Speeten, Kurt; Stuart, O. Anthony; Chang, David; Mahteme, Haile; Sugarbaker, Paul H.
C is a drug often used in this clinical ...
... treated with hyperthermic intraperitoneal  mitomycin 
Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C
Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C
Sugarbaker, Paul H.; Stuart, O. Anthony; Carmignani, C. Pablo
C chemotherapy after a complete ...
... To measure the clearance intraperitoneal  mitomycin 
Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics
Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics
Lima Vazquez, Vinicius; Stuart, O. Anthony; Mohamed, Faheez; Sugarbaker, Paul H.
C and doxorubicin in patients having ...
... radiotherapy with capecitabine and  mitomycin 
Preoperative radiotherapy with capecitabine and mitomycin C in locally advanced rectal carcinoma
Preoperative radiotherapy with capecitabine and mitomycin C in locally advanced rectal carcinoma
Stojanovic, Suzana; Popov, Ivan; Radosevic-Jelic, Ljiljana; Micev, Marjan; Borojevic, Nenad; Nikolic, Vladimir; Krivokapic, Zoran; Kecmanovic, Dragutin; Gavrilovic, Dusica; Kezic, Iva
C in patients with locally advanced rectal ...
... protects hypoxic cells against  mitomycin 
Mitomycin C is not metabolized by but is an inhibitor of human kidney NAD(P)H:(quinone-acceptor)oxidoreductase
Mitomycin C is not metabolized by but is an inhibitor of human kidney NAD(P)H:(quinone-acceptor)oxidoreductase
Schlager, John J.; Powis, Garth
C cytotoxicity by metabolizing ...
... of the combination of docetaxel and  mitomycin 
Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer
Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer
Feliu, J.; Martín, G.; Castro, J.; Sundlov, A.; Rodriguez-Jaráiz, A.; Casado, E.; Lomas, M.; Madroñal, C.; Galán, A.; Belda, C.; Gonzalez-Barón, M.
C as second-line chemotherapy in patients ...
... Summary The bioreductive alkylating agent  mitomycin 
Cytotoxicity of mitomycin C on clonogenic human carcinoma cells is not enhanced by hypoxia
Cytotoxicity of mitomycin C on clonogenic human carcinoma cells is not enhanced by hypoxia
Ludwig, Christian U.; Peng, Yei Mei; Beaudry, Jon N.; Salmon, Sydney E.
C ( ...
... of capecitabine alone or combined with  mitomycin 
Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma
Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma
Cereda, S.; Milella, M.; Cordio, S.; Leone, F.; Aprile, G.; Galiano, A.; Mosconi, S.; Vasile, E.; Santini, D.; Belli, C.; Auriemma, A.; Novarino, A.; Vaccaro, V.; Martines, C.; Marino, D.; Lutrino, S. E.; Palazzo, V.; Reinach, B.; Aldrighetti, L.; Reni, M.
C. ...
... The use of  mitomycin 
Randomized clinical trial of mitomycin-C with or without pretreatment with WR-2721 in patients with advanced colorectal cancer
Randomized clinical trial of mitomycin-C with or without pretreatment with WR-2721 in patients with advanced colorectal cancer
Poplin, Elizabeth A.; LoRusso, Patricia; Lokich, Jacob J.; Gullo, John J.; Leming, Philip D.; Schulz, Joseph J.; Veach, Stephen R.; McCulloch, William; Baker, L.; Schein, Philip
for metastatic colorectal cancer has been ...
... A phase I study of  mitomycin 
Phase I study of mitomycin C and menadione in advanced solid tumors
Phase I study of mitomycin C and menadione in advanced solid tumors
Margolin, Kim A.; Akman, Steven A.; Leong, Lucille A.; Morgan, Robert J.; Somlo, George; Raschko, James W.; Ahn, Chul; Doroshow, James H.
C with menadione ...
... that the ineffectiveness of intravesical  mitomycin 
Bladder tissue pharmacokinetics of intravesical taxol
Bladder tissue pharmacokinetics of intravesical taxol
Song, Di; Wientjes, M. Guillaume; Au, J. L.-S.
C or doxorubicin therapy against ...
... (1) vindesine and cisplatin (VP); (2)  mitomycin 
Cisplatin-based combination chemotherapy for elderly patients with non-small-cell lung cancer
Cisplatin-based combination chemotherapy for elderly patients with non-small-cell lung cancer
Kubota, Kaoru; Furuse, Kiyoyuki; Kawahara, Masaaki; Kodama, Nagahisa; Ogawara, Mitsumasa; Takada, Minoru; Masuda, Noriyuki; Negoro, Shunichi; Matsui, Kaoru; Takifuji, Nobuhide; Kudoh, Shinzou; Kusunoki, Yoko; Fukuoka, Masahiro
, vindesine and cisplatin (MVP); or (3) ...
... with a combination of 5-FU, cisplatin and  mitomycin 
Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial
Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial
Cascinu, Stefano; Galizia, Eva; Labianca, Roberto; Ferraù, Francesco; Pucci, Francesca; Silva, Rosa Rita; Luppi, Gabriele; Beretta, Giordano Domenico; Berardi, Rossana; Scartozzi, Mario
-C. ...
... doxorubicin, etoposide, 5-fluorouracil,  mitomycin 
Synergistic effects of F 11782, a novel dual inhibitor of topoisomerases I and II, in combination with other anticancer agents
Synergistic effects of F 11782, a novel dual inhibitor of topoisomerases I and II, in combination with other anticancer agents
Barret, Jean-Marc; Kruczynski, Anna; Etiévant, Chantal; Hill, Bridget T.
C, paclitaxel, topotecan or vinorelbine. ...
... in combination with either thiotepa or  mitomycin 
Enhanced antitumor activity of irofulven in combination with thiotepa or mitomycin C
Enhanced antitumor activity of irofulven in combination with thiotepa or mitomycin C
Kelner, Michael J.; McMorris, Trevor C.; Rojas, Rafael J.; Trani, Nicole A.; Estes, Leita
C demonstrated a strong synergistic ...
... 1/3 dose 0–1 min, 2/3 dose 1–20 min) and  mitomycin 
A pharmacokinetic model and the clinical pharmacology of cis-platinum, 5-fluorouracil and mitomycin-C in isolated pelvic perfusion
A pharmacokinetic model and the clinical pharmacology of cis-platinum, 5-fluorouracil and mitomycin-C in isolated pelvic perfusion
Wanebo, Harold J.; Belliveau, James F.
-C (11 patients, 14 courses, 10–20 mg/m2, ...
... Summary The alkylating antitumor agents  mitomycin 
Cardiotoxicity of mitomycin A, mitomycin C, and sevenN7 analogs in vitro
Cardiotoxicity of mitomycin A, mitomycin C, and sevenN7 analogs in vitro
Dorr, Robert T.; Shipp, Nancy G.; Liddil, James D.; Iyengar, Bhashyam S.; Kunz, Kenneth R.; Remers, William A.
A (MMA), ...
... of the compound is shown in Fig. 1.  Mitomycin 
In vivo antitumor activity by 2′,4′-dihydroxy-6′-methoxy-3′,5′-dimethylchalcone in a solid human carcinoma xenograft model
In vivo antitumor activity by 2′,4′-dihydroxy-6′-methoxy-3′,5′-dimethylchalcone in a solid human carcinoma xenograft model
Ye, Chun-Lin; Liu, Jian-Wen; Wei, Dong-Zhi; Lu, Yan-Hua; Qian, Feng
-C was purchased from Sigma (St. ...
... of the compound is shown in Fig. 1.  Mitomycin 
In vivo antitumor activity by 2′,4′-dihydroxy-6′-methoxy-3′,5′-dimethylchalcone in a solid human carcinoma xenograft model
In vivo antitumor activity by 2′,4′-dihydroxy-6′-methoxy-3′,5′-dimethylchalcone in a solid human carcinoma xenograft model
Ye, Chun-Lin; Liu, Jian-Wen; Wei, Dong-Zhi; Lu, Yan-Hua; Qian, Feng
-C was purchased from Sigma (St. ...
... plasma elimination and urinary excretion of  mitomycin 
Pharmacokinetics of mitomycin C in rabbit and human
Pharmacokinetics of mitomycin C in rabbit and human
Hazel, Guy A.; Kovach, John S.
C in humans. ...
... hemolytic anemia [14]. While  mitomycin 
Rapid and complete resolution of chemotherapy-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) with rituximab
Rapid and complete resolution of chemotherapy-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) with rituximab
Gourley, Brett L.; Mesa, Hector; Gupta, Pankaj
and cisplatin have been the best described ...
... a 26% response rate; with CDDP, VP-16, and  mitomycin 
A randomized trial of three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group
A randomized trial of three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group
Crino, Lucio; Tonato, Maurizio; Darwish, Samir; Meacci, Maria L.; Corgna, Enrichetta; Costanzo, Francesco; Buzzi, Franco; Fornari, Giovanni; Santi, Emilio; Ballatori, Enzo; Santucci, Carla; Davis, Stephen
-C, a 38% response rate was obtained in ...
... 625 mg/m2 bid on treatment days and  mitomycin 
Concurrent paclitaxel, capecitabine, mitomycin C and pelvic radiation therapy for patients with squamous cell anal carcinoma
Concurrent paclitaxel, capecitabine, mitomycin C and pelvic radiation therapy for patients with squamous cell anal carcinoma
Gordeyev, Sergey S.; Rasulov, Arsen O.; Gorbounova, Vera A.; Tkachev, Sergey I.; Glebovskaya, Valeriya V.; Fedyanin, Mikhail Yu.; Besova, Nataliya S.; Surayeva, Yulia E.
C 10 g/m2 on day 1. ...
... the efficacy of adjuvant chemotherapy with  mitomycin 
Enhanced efficacy of postoperative adjuvant chemotherapy in advanced gastric cancer: results from a phase 3 randomized trial (AMC0101)
Enhanced efficacy of postoperative adjuvant chemotherapy in advanced gastric cancer: results from a phase 3 randomized trial (AMC0101)
Kang, Yoon-Koo; Yook, Jeong Hwan; Chang, Heung-Moon; Ryu, Min-Hee; Yoo, Changhoon; Zang, Dae Young; Lee, Jae-Lyun; Kim, Tae Won; Yang, Dae Hyun; Jang, Se Jin; Park, Young Soo; Lee, Young Jack; Jung, Hwoon-Yong; Kim, Jin-Ho; Kim, Byung Sik
-C and fluoropyrimidine (Mf) in gastric ...
... adriamycin, bleomycin, actinomycin D, and  mitomycin 
Mutagenic effects of some anticancer antibiotics
Mutagenic effects of some anticancer antibiotics
Vig, Baldev K.
C are reviewed. ...